Artwork

Content provided by Robert Pass. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Robert Pass or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Pediheart Podcast #293: Sodium-Glucose Cotransporter 2 Inhibitors For ACHD Heart Failure

35:27
 
Share
 

Manage episode 413311382 series 2087001
Content provided by Robert Pass. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Robert Pass or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This week we review a recent work on the use of sodium-glucose cotransporter 2 inhibitors in the ACHD heart failure patient from Europe. Can these agents impact heart failure outcomes in this patient group? What is the mechanism by which they may improve outcomes? Are there data on their effects on the single ventricle patient? What sorts of side effects can be seen and are these more or less commonly observed in the ACHD patient? We speak with the corresponding author of this week's work, Dr. Anastasia Egorova of Leiden University in the Netherlands.
https://doi.org/10.1016/j.jacc.2024.02.017
  continue reading

466 episodes

Artwork
iconShare
 
Manage episode 413311382 series 2087001
Content provided by Robert Pass. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Robert Pass or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This week we review a recent work on the use of sodium-glucose cotransporter 2 inhibitors in the ACHD heart failure patient from Europe. Can these agents impact heart failure outcomes in this patient group? What is the mechanism by which they may improve outcomes? Are there data on their effects on the single ventricle patient? What sorts of side effects can be seen and are these more or less commonly observed in the ACHD patient? We speak with the corresponding author of this week's work, Dr. Anastasia Egorova of Leiden University in the Netherlands.
https://doi.org/10.1016/j.jacc.2024.02.017
  continue reading

466 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide